In this issue of the e-news, we report on a few additional abstracts that were presented at the December (2019) American Society of Hematology meeting, in Orlando, Florida. The ASH abstract numbers are shown in parentheses. You can search on the number and read the complete abstract at: https://ashpublications.org/blood/issue/134/Supplement_1
CONTENTS:
CONTENTS:
Living with ITP can be frightening for patients and their families and these worries have been worsened in the setting of COVID19. One of the factors that makes ITP so challenging is that it is very hard to predict if and when bleeding may occur, and if bleeding might be severe, even life-threatening. This uncertainty makes it difficult to decide which medication to select, and when and how to deploy it to treat patients. The following two articles discuss risk factors that could help in predicting the development of severe bleeds.
CONTENTS:

CONTENTS:
In this issue of the e-news
CONTENTS:
In this issue of the e-news
CONTENTS:
In this issue of the e-news
CONTENTS:
In this issue of the e-news
CONTENTS:
IMPORTANT!
The Platelet Disorder Support Association does not provide medical advice or endorse any medication, vitamins or herbs. The information contained herein is not intended nor implied to be a substitute for professional medical advice and is provided for educational purposes only. Always seek the advice of your physician or other qualified healthcare provider before starting any new treatment, discontinuing an existing treatment and to discuss any questions you may have regarding your unique medical condition.